Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04563598
Other study ID # UP-16-00706-3
Secondary ID 5R01DK107552
Status Completed
Phase
First received
Last updated
Start date December 19, 2016
Est. completion date June 30, 2023

Study information

Verified date November 2023
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Starting in 2001, the Look AHEAD study randomized patients with type 2 diabetes to an intensive lifestyle intervention (ILI) focused on weight loss versus a control group receiving diabetes education ("Diabetes Support and Education," or DSE). The ILI successfully reduced weight, improved diabetes control, and functional status, among other outcomes. In this study, the investigators will compare employment, earnings, and retirement between the ILI and the control group during and after the intervention period (2001-2018).


Description:

Starting in 2001, the Look AHEAD study randomized 5145 patients with type 2 diabetes to an intensive lifestyle intervention (ILI) focused on weight loss versus a control group receiving diabetes education ("Diabetes Support and Education," or DSE).The Look AHEAD study tested whether participants with type 2 diabetes assigned to an intensive lifestyle intervention (ILI) for weight loss exhibited reductions in cardiovascular morbidity and mortality, relative to a control group receiving usual care and diabetes support and education. During the 12-year intervention period, the ILI led to persistent reductions in weight, waist circumference, and hemoglobin A1c and improvements in physical fitness, among other clinical benefits. After the conclusion of the intervention in 2012, participants were consented to be linked with administrative data. The investigators attempted to link 3188 consenting participants with Social Security Administration databases. Of these, the investigators were able to successfully link 3093 participants. In this study, the investigators will compare employment, earnings, and retirement between the ILI and the control group during and after the intervention period (2001-2018). The investigators will determine ILI-versus-control differences in employment, earnings, and retirement in each year after randomization, relative to a pre-randomization assessment period. The investigators will also investigate ILI-versus-control differences in cumulative years of employment and earnings after randomization which occurred between 2001-2004. The investigators will use multivariate regressions controlling for baseline participant characteristics and clinic site and also survival analyses that estimate whether the time until retirement differs between the ILI and control groups.


Recruitment information / eligibility

Status Completed
Enrollment 3091
Est. completion date June 30, 2023
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 45 Years to 75 Years
Eligibility (Note: age limits above are at time of randomization, which occurred between 2001-2004) Inclusion Criteria: - Look AHEAD participation: met age requirements and other criteria at time of study enrollment which occurred between 2001-2004 (as noted in Look AHEAD Research Group (2013)) - Consented to administrative data linkages - Provided individual identifiers that could be linked with Social Security Administration databases - Were successfully linked to Social Security Administration data Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intensive lifestyle intervention (ILI)
Lifestyle intervention focused on weight loss through diet and physical activity
Diabetes support and education (DSE)
Behavioral intervention focused on diabetes support and education

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University of Minnesota National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Southern California, Wake Forest University

References & Publications (1)

Look AHEAD Research Group; Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24. Erratum In: N Engl J Med. 2014 May 8;370(19):1866. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Number of employers (unique employer IDs) per study year (excluding unemployed study participants) This measure is based on Social Security Administration data on employers 12-month intervals relative to randomization occurring between 2001-2018
Other Started a new job (new employer ID) by study year (all study participants) This measure is based on Social Security Administration data on employment 12-month intervals relative to randomization occurring between 2001-2018
Other Started a new job (new employer ID) by study year (excluding unemployed study participants) This measure is based on Social Security Administration data on employment 12-month intervals relative to randomization occurring between 2001-2018
Other Received any Supplemental Security Income (SSI) benefits at age 65 since randomization (all study participants) This measure is based on Social Security Administration data indicating SSI benefits and SSI eligibility 12-month intervals relative to randomization occurring between 2001-2018
Other Received any self-employment income by study year (all study participants) This measure is based on Social Security Administration data on earnings 12-month intervals relative to randomization occurring between 2001-2018
Other Received any income from pensions or distributions from retirement accounts by study year (all study participants) This measure is based on Social Security Administration data on earnings 12-month intervals relative to randomization occurring between 2001-2018
Other Total compensation (from employment, self-employment, pensions, and distributions from retirement accounts (all study participants) This measure is based on Social Security Administration data on compensation 12-month intervals relative to randomization occurring between 2001-2018
Other Ever retired after randomization (all study participants) This measure is based on Social Security Administration data on retirement entitlement/election From initial randomization (occurred between 2001-2004) through 2018
Other Ever worked past minimum retirement age (partial benefits, age 62; excluding unemployed study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2018
Other Ever worked past minimum retirement age (full benefits, age 65 or 66 depending on date of birth; excluding unemployed study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2018
Other Total compensation (from employment, self-employment, pensions, and distributions from retirement accounts) after randomization (all study participants) This measure is based on Social Security Administration data on compensation From initial randomization (occurred between 2001-2004) through 2018
Other Ever employed (any earnings from employment and/or self-employment) during first 10 years after randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2014
Other Total person-years employed (any earnings from employment and/or self-employment) during first 10 years after randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2014
Other Total earnings (from employment and/or self-employment) during first 10 years after randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2014
Other Total compensation (from employment, self-employment, pensions, and distributions from retirement accounts) during first 10 years after randomization (all study participants) This measure is based on Social Security Administration data on compensation From initial randomization (occurred between 2001-2004) through 2014
Other Ever retired during first 10 years after randomization (all study participants) This measure is based on Social Security Administration data on retirement entitlement/election From initial randomization (occurred between 2001-2004) through 2014
Primary Employed (any earnings from employment or self-employment) by study year (all study participants) This measure is based on Social Security Administration data on earnings 12-month intervals relative to randomization occurring between 2001-2018
Primary Total earnings from employment and/or self-employment by study year (all study participants) This measure is based on Social Security Administration data on earnings; earnings for unemployed study participants will be captured as zeros. 12-month intervals relative to randomization occurring between 2001-2018
Secondary Retired (any Social Security retirement entitlement/election) by study year (all study participants) This measure is based on Social Security Administration data on retirement entitlement/election 12-month intervals relative to randomization occurring between 2001-2018
Secondary Total earnings from employment and/or self-employment by study year (excluding unemployed study participants) This measure is based on Social Security Administration data on earnings 12-month intervals relative to randomization occurring between 2001-2018
Secondary Total person-years from randomization to retirement (all study participants) This measure is based on Social Security Administration data on retirement entitlement/election From initial randomization (occurred between 2001-2004) through 2018
Secondary Total person-years employed since randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2018
Secondary Ever employed (any earnings from employment or self-employment) after randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2018
Secondary Total earnings from employment and/or self-employment since randomization (all study participants) This measure is based on Social Security Administration data on earnings From initial randomization (occurred between 2001-2004) through 2018
Secondary Ever received Supplemental Security Income (SSI) benefits at age 65 since randomization (all study participants) This measure is based on Social Security Administration data indicating SSI benefits and SSI eligibility. From initial randomization (occurred between 2001-2004) through 2018
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2